ImmunotherapyBusulfanTransplantation ConditioningWhole-Body IrradiationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveGraft vs Host DiseaseCyclophosphamideTransplantation, AutologousVidarabineImmunotherapy, ActiveMyeloablative AgonistsDesensitization, ImmunologicAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeActuarial AnalysisCombined Modality TherapyHematologic NeoplasmsMelphalanTransplantation ChimeraThiotepaRecurrenceHistocompatibilityAntilymphocyte SerumSurvival AnalysisImmunosuppressive AgentsGraft SurvivalDisease-Free SurvivalGraft vs Tumor EffectEtoposideCancer VaccinesAntineoplastic Agents, AlkylatingHistocompatibility TestingCarmustineCord Blood Stem Cell TransplantationLeukemiaRemission InductionBone Marrow PurgingHepatic Veno-Occlusive DiseaseLymphoma, Non-HodgkinAntibodies, MonoclonalNeoplasmsAntigens, NeoplasmTissue DonorsSurvival RateLymphocyte DepletionCountercurrent DistributionRetrospective StudiesDrug Administration ScheduleHematologic DiseasesLeukemia, MyeloidAdministration, SublingualLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsGraft RejectionAnemia, AplasticLeukemia, Myeloid, AcuteAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseMyelodysplastic SyndromesSublingual ImmunotherapyDrug Therapy, CombinationFollow-Up StudiesRhinitis, Allergic, SeasonalT-Lymphocytes, CytotoxicT-LymphocytesPrognosisHLA AntigensDendritic CellsMelanomaAllergensInterleukin-2Isoelectric FocusingMolecular WeightChromatography, High Pressure LiquidClinical Trials as TopicElectrophoresis, Polyacrylamide GelCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingMice, Inbred C57BLAntineoplastic AgentsMelanoma, ExperimentalMice, Inbred BALB CImmunization, PassiveCytotoxicity, ImmunologicLymphocyte ActivationHLA-A2 AntigenDose-Response Relationship, DrugBee VenomsVincristineCell Line, TumorChromatography, Thin LayerImmunoglobulin EBCG VaccinePollenTumor EscapeAdjuvants, Immunologic